SB
BRLI

Suntrust Banks’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Suntrust Banks’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-7,133
Closed -$212K – 1923
2013
Q3 		$212K Buy
+7,133
New +$198K ﹤0.01% 1652

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CM
CS McKee Pittsburgh, Pennsylvania $1.09B AUM 31.33% 1-Year Est. Return

Suntrust Banks's BRLI Position: Q4 2013 in Review

Suntrust Banks sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q4 2013, closing a stake of 7,133 shares — an estimated $212K sold.

Suntrust Banks first reported a position in BRLI in Q3 2013 and held it in 1 quarter. The position peaked at $212K in Q3 2013. 175 funds tracked by Wall St. Rank hold BRLI as of Q4 2013.

  • Suntrust Banks reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q4 2013 after selling out during the quarter.
  • Suntrust Banks sold 7,133 BIO-REFERENCE LABS INC-NEW- shares in Q4 2013, an estimated $212K.
  • Suntrust Banks first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 1 quarter.
  • Suntrust Banks's BIO-REFERENCE LABS INC-NEW- position peaked at $212K in Q3 2013.
  • 175 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2013.

Based on Suntrust Banks's 13F filing for Q4 2013, filed 12 Feb 2014.